98%
921
2 minutes
20
Peroneus longus tendon (PLT) graft has recently gained visibility in the literature as a promising option for knee ligament reconstructions. The most used harvesting technique is performed with a single incision posterior to the lateral malleolus, with large series reporting tendon lengths enough to prepare a double or triple anterior cruciate ligament (ACL) graft, resulting in mean diameters greater than 8.0 mm. However, as happens with the hamstrings, some patients may present PLT grafts with a 7-mm diameter, which is associated with higher failure rates and is the minimum acceptable diameter for ACL reconstructions. In turn, the 2-incision technique has longer graft lengths reported, enough to prepare 4-folded grafts, with mean diameters above 9.0 mm, ranging from 8.5 to 10 mm. Once the PLT graft diameter has a direct correlation with anthropometric measurements, as well as larger ACL graft diameters are associated with lower failure rates and revision surgeries, the inframalleolar harvesting seems to be a reasonable option, especially for short-stature patients with a greater risk of insufficient grafts. Additionally, patients who benefit from an extra-articular procedure can have a combined reconstruction of the ACL and anterolateral ligament using the PLT graft with the two-incision technique, with no need for another graft. Therefore, this article aims to describe the step-by-step technique for the inframalleolar PLT harvesting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jisako.2025.100384 | DOI Listing |
Eur Radiol
September 2025
Interventional Radiology Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Objectives: Biodegradable biliary stents are used to treat benign biliary strictures in adults. However, there is limited data regarding their use in pediatric patients. This study aims to assess the efficacy and safety of biodegradable biliary stents following pediatric liver transplantation (pLT).
View Article and Find Full Text PDFTransplantation
September 2025
The Institute of Liver Disease & Transplantation, Dr Rela Institute & Medical Centre, Bharath Institute of Higher Education & Research, Chennai, India.
Background: Acceptance of pediatric liver transplantation (PLT) in this part of the world has been slow because of a number of considerations, including those of cost, infections, and the nonavailability of expertise. Despite several obstacles, PLT has seen impressive growth in the recent years. Against a backdrop of this changing landscape of PLT in India, we present our experience of performing 700 PLT over a period of 13 y.
View Article and Find Full Text PDFWorld J Transplant
September 2025
Roger Williams Institute of Liver Studies, King's College London, London SE5 9NT, United Kingdom.
Paediatric liver transplantation (PLT) is a life-saving procedure for children with advanced liver disease or hepatoblastoma. The number of available grafts is limited in relation to the number of children on PLT waiting list. This graft shortage has led transplant societies and healthcare organizations to explore ways to investigate possible options and expand the donor pool.
View Article and Find Full Text PDFPediatr Transplant
September 2025
Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, Brazil.
Pediatric liver transplantation (PLT) is challenged by anatomical variability and small vessel size, especially in partial grafts. This review outlines strategies to minimize and manage complications of hepatic vein (HV) and portal vein (PV) reconstruction. HV reconstruction employs vein unification, direct caval implantation, or interposition grafts to prevent outflow obstruction, with diagnosis and management guided by imaging and interventional radiology.
View Article and Find Full Text PDFAnn Hematol
August 2025
Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a high-risk malignancy with poor outcomes due to frequent relapse. The prognostic role of minimal residual disease (MRD) dynamic monitoring in adult T-ALL/LBL needs further validation across chemotherapy and transplantation phases. This large-scale study aimed to assess multi-timepoint MRD as a predictive biomarker, and integrated risk factors in adult T-ALL/LBL.
View Article and Find Full Text PDF